Rinucumab (REGN 2176) is an anti-platelet-derived growth factor (PDGF) IgG4-like monoclonal antibody that acts by binding to the PDGF-beta receptor and can be used to study age-related macular degeneration.
Purity:
0.992
CAS Number:
[1569263-06-4]
Target:
PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted